Psychotropic dose equivalence in Japan

Psychiatry and Clinical Neurosciences

Volumn 69, Issue 8, 2015, Pages 440-447

  Inada, Toshiya ^a   Inagaki, Ataru ^b  

^a SEIWA HOSPITAL   (Japan)

^b AOYAMA GAKUIN UNIVERSITY   (Japan)

Author keywords

antidepressant; antiparkinsonian drugs; antipsychotic; anxiolytic; dose equivalence; hypnotic

Indexed keywords

AMANTADINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BENZATROPINE; BIPERIDEN; CHLORPROMAZINE; CLOBAZAM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; DIPHENHYDRAMINE; DOSULEPIN; DULOXETINE; ESCITALOPRAM; FLUPHENAZINE; HALOPERIDOL; HYPNOTIC AGENT; IMIPRAMINE; MIRTAZAPINE; NEUROLEPTIC AGENT; NITRAZEPAM; PALIPERIDONE; PSYCHOTROPIC AGENT; RISPERIDONE; SECOBARBITAL; SEDATIVE AGENT; TANDOSPIRONE; UNINDEXED DRUG; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DOSE EQUIVALENCE; DRUG DOSE; DRUG EFFICACY; DRUG MARKETING; HUMAN; INSOMNIA; JAPAN; MEDICAL DECISION MAKING; PHARMACOLOGICAL PARAMETERS; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPEUTIC EQUIVALENCE;

ANTIDEPRESSIVE AGENTS; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; HUMANS; HYPNOTICS AND SEDATIVES; JAPAN; PSYCHOTROPIC DRUGS; THERAPEUTIC EQUIVALENCY;

EID: 84938202522     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12275     Document Type: Article

References (46)

1. Inagaki A, Inada T, Fujii Y, et al. Dose Equivalence of Psychotropic Drugs. Seiwa Shoten Publishers, Inc., Tokyo, 1999 (in Japanese).
2. Binder RL, Kazamatsuri H, Nishimura T, McNiel DE,. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Am. J. Psychiatry 1987; 144: 1494-1496.
3. Kubota T, Chiba K, Iga T,. Frequency distribution of CYP2C19, CYP2D6, and CYP2C19 mutant-alleles in several different populations. Yakubutsu dotai (Xenobio Metabol and Dispos) 2001; 16: 69-74 (in Japanese).
4. Furukawa T, Inada T, Adams CE, McGuire H, Inagaki A, Nozaki S,. Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials. BMC Med. Res. Methodol. 2002; 2: 6.
5. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [1] Dose equivalence of orally administered neuroleptics (1). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 101-103 (in Japanese).
6. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [2] Dose equivalence of orally administered neuroleptics (2). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 215-219 (in Japanese).
7. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [3] Dose equivalence of orally administered neuroleptics (3). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 335-339 (in Japanese).
8. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [4] Dose equivalence of orally administered neuroleptics (4). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 443-448 (in Japanese).
9. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [14] Dose equivalence of novel antipsychotics (1): Quetiapine. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2001; 4: 681-684 (in Japanese).
10. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [15] Dose equivalence of novel antipsychotics (2): Perospirone. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2001; 4: 869-870 (in Japanese).
11. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [16] Dose equivalence of novel antipsychotics (3): Olanzapine. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2001; 4: 997-1000 (in Japanese).
12. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [17] Dose equivalence of novel antipsychotics (4): Aripiprazole. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2006; 9: 249-258 (in Japanese).
13. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [18] Dose equivalence of psychotropic drugs: 2006 version. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2006; 9: 1443-1447 (in Japanese).
14. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [21] Dose equivalence of novel antipsychotics (5): Blonanserin. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2008; 11: 887-890 (in Japanese).
15. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [23] Dose equivalence of novel antipsychotics: Paliperidone extended release. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2012; 15: 397-404 (in Japanese).
16. Davis JM,. Dose equivalence of the antipsychotic drugs. J. Psychiatr. Res. 1974; 11: 65-69.
17. Lehman AF, Steinwachs DM, the Co-investigators of the PORT Project. At issue: Translating research into practice: The schizophrenia Patients Outcomes Research Team (PORT) treatment recommendations. Schizophr. Bull. 1998; 24: 1-10.
18. Gelder MG, Lopez-Ibor JJ, Andreasen NC, (eds). New Oxford Textbook of Psychiatry. Oxford University Press, New York, 2000.
19. Meltzer HY, Fatemi H,. Schizophrenia. In:, Eberts MH, Loosen PT, Nurcimbe B, (eds). Current Diagnosis & Treatment in Psychiatry. McGraw-Hill, New York, 2000; 260-277.
20. Sadock BJ, Sadock VA,. Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, 2001.
21. Centorrino F, Eakin M, Bahk WM, et al. Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am. J. Psychiatry 2002; 159: 1932-1935.
22. Humberstone V, Wheeler A, Lambert T,. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. Aust. N. Z. J. Psychiatry 2003; 38: 240-245.
23. Woods SW,. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003; 64: 663-667.
24. Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The schizophrenia Patients Outcomes Research Team (PORT): Update treatment recommendations 2003. Schizophr. Bull. 2004; 30: 193-217.
25. Marangell LB, Silver JM, Goff DC, et al. Psychopharmacology and electroconvulsive therapy. In:, Hales RE, Yudofsky SC, (eds). Essentials of Clinical Psychiatry, 2nd edn. American Psychiatric Publishing, Washington, 2004; 783-888.
26. Kamijima K, Shishikura K,. Dose equivalency and adequate dose of atypical antipsychotic, quetiapine. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2004; 7: 1385-1389.
27. Akimoto T, Miyamoto S, Aoba A,. Dosing strategy for Quetiapine: Its determination and adjustment in schizophrenia. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2005; 8: 1199-1207 (in Japanese).
28. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [20] Dose equivalence of injectable antipsychotics. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2007; 10: 2373-2377 (in Japanese).
29. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [5] Dose equivalence of depot neuroleptics (1). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 557-561 (in Japanese).
30. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [6] Dose equivalence of depot neuroleptics (2). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 663-666 (in Japanese).
31. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [22] Dose equivalence of depot antipsychotics: Risperidone long-acing injection. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2010; 13: 1349-1353 (in Japanese).
32. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [8] Dose equivalence of antiparkinsonian drugs (1). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 887-890 (in Japanese).
33. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [9] Dose equivalence of antiparkinsonian drugs (2). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 969-972 (in Japanese).
34. Bezchlibnyk-Butler KZ, Remington GJ,. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Can. J. Psychiatry 1994; 39: 74-84.
35. de Leon J, Canuso C, White AO, et al. A pilot effort to determine benztropine equivalents of anticholinergic medications. Hosp. Community Psychiatry 1994; 45: 606-607.
36. Klett CJ, Point M, Caffey E,. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Arch. Gen. Psychiatry 1972; 26: 374-379.
37. Tran PV, Dellva MA, Tollefson GD, et al. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. J. Clin. Psychiatry 1997; 58: 205-211.
38. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [10] Dose equivalence of antidepressants (1). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 1087-1092 (in Japanese).
39. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [11] Dose equivalence of antidepressants (2). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1998; 1: 1209-1215 (in Japanese).
40. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [19] Dose equivalence of novel antidepressants (1): Sertraline. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2006; 9: 1859-1864 (in Japanese).
41. Ali IM,. Long-term treatment with antidepressants in primary care. Psychiatr Bull 1998; 22: 15-19.
42. Fava M, Davidson KG,. Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 1996; 19: 179-200.
43. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [12] Dose equivalence of anxiolytic drugs, sedatives and hypnotics (1). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1999; 2: 297-302 (in Japanese).
44. Inagaki A, Inada T, Fujii Y, Yagi G,. Dose equivalence of psychotropic drugs. [13] Dose equivalence of anxiolytic drugs, sedatives and hypnotics (2). Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 1999; 2: 411-416 (in Japanese).
45. Inagaki A, Inada T,. Dose equivalence of psychotropic drugs. [24] Dose equivalence of anti-anxiolytics/hypnotics (3): Eszopiclone. Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.) 2012; 15: 1403-1406 (in Japanese).
46. Inada T, Nozaki S, Inagaki A, Furukawa T,. Efficacy of diazepam as an anti-anxiety agent: Meta-analysis of the double-blind randomized controlled trials in Japan. Hum Psychopharmacol Clin Exp 2003; 18: 483-487.